Statins and the endothelium

Vascular Pharmacology

Volumn 46, Issue 1, 2007, Pages 1-9

  Ii, Masaaki ^a,b   Losordo, Douglas W ^c  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelium; Statin

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ATHEROSCLEROSIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STEM CELLS;

EID: 33845226667     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.06.012     Document Type: Review

References (107)

1. Abbruzzese T.A., Havens J., Belkin M., Donaldson M.C., Whittemore A.D., Liao J.K., and Conte M.S. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J. Vasc. Surg. 39 (2004) 1178-1185
2. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A.M., and Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9 (2003) 1370-1376
3. Aikawa M., Sugiyama S., Hill C.C., Voglic S.J., Rabkin E., Fukumoto Y., Schoen F.J., Witztum J.L., and Libby P. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106 (2002) 1390-1396
4. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70
5. Amano K., Matsubara H., Iba O., Okigaki M., Fujiyama S., Imada T., Kojima H., Nozawa Y., Kawashima S., Yokoyama M., and Iwasaka T. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41 (2003) 156-162
6. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
7. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., and Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
8. Asakage M., Tsuno N.H., Kitayama J., Kawai K., Okaji Y., Yazawa K., Kaisaki S., Takahashi K., and Nagawa H. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest. Anticancer Drugs 15 (2004) 625-632
9. Assmus B., Urbich C., Aicher A., Hofmann W.K., Haendeler J., Rossig L., Spyridopoulos I., Zeiher A.M., and Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res. 92 (2003) 1049-1055
10. Baumann H., and Gauldie J. The acute phase response. Immunol. Today 15 (1994) 74-80
11. Brevetti L.S., Chang D.S., Tang G.L., Sarkar R., and Messina L.M. Overexpression of endothelial nitric oxide synthase increases skeletal muscle blood flow and oxygenation in severe rat hind limb ischemia. J. Vasc. Surg. 38 (2003) 820-826
12. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., and Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103 (2001) 423-428
13. Brouet A., Sonveaux P., Dessy C., Moniotte S., Balligand J.L., and Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ. Res. 89 (2001) 866-873
14. Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., Joyal S.V., Hill K.A., Pfeffer M.A., and Skene A.M. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 350 (2004) 1495-1504
15. Cayatte A.J., Palacino J.J., Horten K., and Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14 (1994) 753-759
16. Che W., Lerner-Marmarosh N., Huang Q., Osawa M., Ohta S., Yoshizumi M., Glassman M., Lee J.D., Yan C., Berk B.C., and Abe J. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 90 (2002) 1222-1230
17. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., Zhang C., Lu M., Katakowski M., Feldkamp C.S., and Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53 (2003) 743-751
18. Cho H.J., Kim H.S., Lee M.M., Kim D.H., Yang H.J., Hur J., Hwang K.K., Oh S., Choi Y.J., Chae I.H., Oh B.H., Choi Y.S., Walsh K., and Park Y.B. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 108 (2003) 2918-2925
19. Chung H.K., Lee I.K., Kang H., Suh J.M., Kim H., Park K.C., Kim D.W., Kim Y.K., Ro H.K., and Shong M. Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp. Mol. Med. 34 (2002) 451-461
20. Demierre M.F., Higgins P.D., Gruber S.B., Hawk E., and Lippman S.M. Statins and cancer prevention. Nat. Rev., Cancer 5 (2005) 930-942
21. Diaz-Sandoval L.J., and Losordo D.W. Gene therapy for cardiovascular angiogenesis. Expert Opin. Biol. Ther. 3 (2003) 599-616
22. Dichtl W., Nilsson L., Goncalves I., Ares M.P., Banfi C., Calara F., Hamsten A., Eriksson P., and Nilsson J. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ. Res. 84 (1999) 1085-1094
23. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., and Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108 (2001) 391-397
24. Diodati J.G., Dakak N., Gilligan D.M., and Quyyumi A.A. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation 98 (1998) 17-24
25. Duprez D., De Buyzere M., Dhondt E., and Clement D.L. Impaired microcirculation in heart failure. Int. J. Microcirc. Clin. Exp. 16 (1996) 137-142
26. Faust J.R., Brown M.S., and Goldstein J.L. Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts. J. Biol. Chem. 255 (1980) 6546-6548
27. Feng C., Ye C., Liu X., Ma H., and Li M. Beta4 integrin is involved in statin-induced endothelial cell death. Biochem. Biophys. Res. Commun. 323 (2004) 858-864
28. Frank H., Schobel H.P., Heusser K., Geiger H., Fahlbusch R., and Naraghi R. Long-term results after microvascular decompression in essential hypertension. Stroke 32 (2001) 2950-2955
29. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., Jin D., Takai S., Miyazaki M., Egashira K., Imada T., Iwasaka T., and Matsubara H. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ. Res. 93 (2003) 980-989
30. Harris M.B., Blackstone M.A., Sood S.G., Li C., Goolsby J.M., Venema V.J., Kemp B.E., and Venema R.C. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H560-H566
31. Hayashi K., Nakamura S., Morishita R., Moriguchi A., Aoki M., Matsumoto K., Nakamura T., Kaneda Y., Sakai N., and Ogihara T. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther. 7 (2000) 1664-1671
32. Hernandez-Perera O., Perez-Sala D., Navarro-Antolin J., Sanchez-Pascuala R., Hernandez G., Diaz C., and Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101 (1998) 2711-2719
33. Hutter R., Carrick F.E., Valdiviezo C., Wolinsky C., Rudge J.S., Wiegand S.J., Fuster V., Badimon J.J., and Sauter B.V. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110 (2004) 2430-2435
34. Ichiki T., Takeda K., Tokunou T., Iino N., Egashira K., Shimokawa H., Hirano K., Kanaide H., and Takeshita A. Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1896-1901
35. Ii M., Nishimura H., Kusano F.K., Qin G., Yoon Y.S., Wecker A., Asahara T., and Losordo D.W. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa vasorum and reversal of diabetic neuropathy. Circulation 112 (2005) 93-102
36. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J.M., Asahara T., and Losordo D.W. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 (2003) 3115-3121
37. Johnson D.R., Hauser I.A., Voll R.E., and Emmrich F. Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones. J. Leukoc. Biol. 63 (1998) 612-619
38. Kaneta S., Satoh K., Kano S., Kanda M., and Ichihara K. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atherosclerosis 170 (2003) 237-243
39. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., Silver M., Ma H., Kearney M., Isner J.M., and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
40. Kinlay S., and Ganz P. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy. Am. J. Cardiol. 86 (2000) 10J-13J (discussion 13J-14J)
41. Klag M.J., Ford D.E., Mead L.A., He J., Whelton P.K., Liang K.Y., and Levine D.M. Serum cholesterol in young men and subsequent cardiovascular disease. N. Engl. J. Med. 328 (1993) 313-318
42. Kong D., Melo L.G., Gnecchi M., Zhang L., Mostoslavsky G., Liew C.C., Pratt R.E., and Dzau V.J. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
43. Krasinski K., Spyridopoulos I., Asahara T., van der Zee R., Isner J.M., and Losordo D.W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95 (1997) 1768-1772
44. Krasinski K., Spyridopoulos I., Kearney M., and Losordo D.W. In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation 104 (2001) 1754-1756
45. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4651-4655
46. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., Sessa W.C., and Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6 (2000) 1004-1010
47. Landmesser U., Engberding N., Bahlmann F.H., Schaefer A., Wiencke A., Heineke A., Spiekermann S., Hilfiker-Kleiner D., Templin C., Kotlarz D., Mueller M., Fuchs M., Hornig B., Haller H., and Drexler H. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110 (2004) 1933-1939
48. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273 (1998) 24266-24271
49. Laufs U., Fata V.L., and Liao J.K. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J. Biol. Chem. 272 (1997) 31725-31729
50. Laufs U., Endres M., Custodis F., Gertz K., Nickenig G., Liao J.K., and Bohm M. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102 (2000) 3104-3110
51. Liao J.K. Statin therapy for cardiac hypertrophy and heart failure. J. Investig. Med. 52 (2004) 248-253
52. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., and Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 108 (2001) 399-405
53. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., Ashare A.B., Lathi K., and Isner J.M. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800-2804
54. Martin-Nizard F., Houssaini H.S., Lestavel-Delattre S., Duriez P., and Fruchart J.C. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett. 293 (1991) 127-130
55. Matsuno H., Takei M., Hayashi H., Nakajima K., Ishisaki A., and Kozawa O. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J. Cardiovasc. Pharmacol. 43 (2004) 333-340
56. Monaco C., Andreakos E., Young S., Feldmann M., and Paleolog E. T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J. Leukoc. Biol. 71 (2002) 659-668
57. Mulhaupt F., Matter C.M., Kwak B.R., Pelli G., Veillard N.R., Burger F., Graber P., Luscher T.F., and Mach F. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc. Res. 59 (2003) 755-766
58. Namba T., Koike H., Murakami K., Aoki M., Makino H., Hashiya N., Ogihara T., Kaneda Y., Kohno M., and Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108 (2003) 2250-2257
59. Newton C.J., Ran G., Xie Y.X., Bilko D., Burgoyne C.H., Adams I., Abidia A., McCollum P.T., and Atkin S.L. Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone. J. Endocrinol. 174 (2002) 7-16
60. Node K., Fujita M., Kitakaze M., Hori M., and Liao J.K. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108 (2003) 839-843
61. Numaguchi Y., Okumura K., Harada M., Naruse K., Yamada M., Osanai H., Matsui H., Ito M., and Murohara T. Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries. Cardiovasc. Res. 61 (2004) 177-185
62. O'Driscoll G., Green D., and Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 (1997) 1126-1131
63. Okouchi M., Okayama N., Omi H., Imaeda K., Shimizu M., Fukutomi T., and Itoh M. Cerivastatin ameliorates high insulin-enhanced neutrophil-endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation. J. Diabetes Its Complicat. 17 (2003) 380-386
64. Packard C. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97 (1998) 1440-1445
65. Panza J.A., Garcia C.E., Kilcoyne C.M., Quyyumi A.A., and Cannon III R.O. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91 (1995) 1732-1738
66. Park H.J., Kong D., Iruela-Arispe L., Begley U., Tang D., and Galper J.B. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ. Res. 91 (2002) 143-150
67. Pham H.T., Economides P.A., and Veves A. The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes. Clin. Podiatr. Med. Surg. 15 (1998) 85-93
68. Rasmussen L.M., Hansen P.R., Nabipour M.T., Olesen P., Kristiansen M.T., and Ledet T. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem. J. 360 (2001) 363-370
69. Rauch U., Osende J.I., Chesebro J.H., Fuster V., Vorchheimer D.A., Harris K., Harris P., Sandler D.A., Fallon J.T., Jayaraman S., and Badimon J.J. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis 153 (2000) 181-189
70. Rezaie-Majd A., Prager G.W., Bucek R.A., Schernthaner G.H., Maca T., Kress H.G., Valent P., Binder B.R., Minar E., and Baghestanian M. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 397-403
71. Rice J.B., Stoll L.L., Li W.G., Denning G.M., Weydert J., Charipar E., Richenbacher W.E., Miller Jr. F.J., and Weintraub N.L. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1576-1582
72. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F., and Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100 (1999) 230-235
73. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles J.S., and Gotto Jr. A.M. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344 (2001) 1959-1965
74. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
75. Rupp S., Badorff C., Koyanagi M., Urbich C., Fichtlscherer S., Aicher A., Zeiher A.M., and Dimmeler S. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res. Cardiol. 99 (2004) 61-68
76. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica J.W., Arnold J.M., Wun C.C., Davis B.R., and Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 335 (1996) 1001-1009
77. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., and Webb R.C. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78 (1996) 225-230
78. Sasaguri Y., and Tanimoto A. Role of macrophage-derived histamine in atherosclerosis-chronic participation in the inflammatory response. J. Atheroscler. Thromb. 11 (2004) 122-130
79. Sata M., Nishimatsu H., Suzuki E., Sugiura S., Yoshizumi M., Ouchi Y., Hirata Y., and Nagai R. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J. 15 (2001) 2530-2532
80. Schaefer C.A., Kuhlmann C.R., Gast C., Weiterer S., Li F., Most A.K., Neumann T., Backenkohler U., Tillmanns H., Waldecker B., Wiecha J., and Erdogan A. Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells. Vascul. Pharmacol. 41 (2004) 67-73
81. Schmidt A., Goepfert C., Feitsma K., and Buddecke E. Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-alpha activated human vascular endothelial cells. Atherosclerosis 164 (2002) 57-64
82. Schratzberger P., Schratzberger G., Silver M., Curry C., Kearney M., Magner M., Alroy J., Adelman L.S., Weinberg D.H., Ropper A.H., and Isner J.M. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6 (2000) 405-413
83. Schratzberger P., Walter D.H., Rittig K., Bahlmann F.H., Pola R., Curry C., Silver M., Krainin J.G., Weinberg D.H., Ropper A.H., and Isner J.M. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107 (2001) 1083-1092
84. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., and Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
85. Skaletz-Rorowski A., Lutchman M., Kureishi Y., Lefer D.J., Faust J.R., and Walsh K. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc. Res. 57 (2003) 253-264
86. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., Laufs K., Ghaeni L., Milosevic M., Bohm M., and Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
87. Sung J.M., Hsu S.C., Chen F.F., and Huang J.J. Systemic lupus erythematosus presented as non-inflammatory necrotizing vasculopathy-induced ischemic glomerulopathy and small vessels-related ischemic cardiomyopathy. Lupus 11 (2002) 458-462
88. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
89. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., and Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95 (1997) 76-82
90. Tomita N., Morishita R., Higaki J., and Ogihara T. Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor. J. Atheroscler. Thromb. 7 (2000) 1-7
91. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S., Zhang J., Boccuzzi S.J., Cedarholm J.C., and Alexander R.W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N. Engl. J. Med. 332 (1995) 481-487
92. Urbich C., and Dimmeler S. CD40 and vascular inflammation. Can. J. Cardiol. 20 (2004) 681-683
93. Urbich C., Dernbach E., Zeiher A.M., and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ. Res. 90 (2002) 737-744
94. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., and Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
95. Vincent L., Chen W., Hong L., Mirshahi F., Mishal Z., Mirshahi-Khorassani T., Vannier J.P., Soria J., and Soria C. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett. 495 (2001) 159-166
96. Vincent L., Soria C., Mirshahi F., Opolon P., Mishal Z., Vannier J.P., Soria J., and Hong L. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 623-629
97. Vincent L., Albanese P., Bompais H., Uzan G., Vannier J.P., Steg P.G., Soria J., and Soria C. Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Thromb. Haemost. 89 (2003) 530-537
98. Wagner A.H., Gebauer M., Guldenzoph B., and Hecker M. 3-Hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1784-1789
99. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D.W., Asahara T., and Isner J.M. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
100. Walter D.H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P.W., Tietz A.B., Kirchmair R., Silver M., Curry C., Wecker A., Yoon Y.S., Heidenreich R., Hanley A., Kearney M., Tio F.O., Kuenzler P., Isner J.M., and Losordo D.W. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110 (2004) 36-45
101. Wang C.H., Ciliberti N., Li S.H., Szmitko P.E., Weisel R.D., Fedak P.W., Al-Omran M., Cherng W.J., Li R.K., Stanford W.L., and Verma S. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109 (2004) 1392-1400
102. Weber C. Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunol. Res. 15 (1996) 30-37
103. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 (2002) 739-745
104. Werner N., Priller J., Laufs U., Endres M., Bohm M., Dirnagl U., and Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1567-1572
105. Wilson R.F., Laxson D.D., Lesser J.R., and White C.W. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1 (1989) 807-811
106. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., and Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
107. Zioupos P., Barbenel J.C., Lowe G.D., and MacRury S. Foot microcirculation and blood rheology in diabetes. J. Biomed. Eng. 15 (1993) 155-158